Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -224,187 | -155,614 | -89,444 | -37,427 | -160,158 |
| Depreciation Amortization | 13,533 | 10,938 | 7,052 | 3,506 | 14,042 |
| Income taxes - deferred | -2,938 | -2,731 | -1,029 | -1,067 | -8 |
| Accounts payable and accrued liabilities | 2,570 | 7,275 | 2,287 | -1,724 | 1,188 |
| Other Working Capital | 16,360 | 13,279 | 419 | 53 | -15,636 |
| Other Operating Activity | 22,938 | 12,733 | 3,586 | 5,552 | 8,463 |
| Operating Cash Flow | $-171,724 | $-114,120 | $-77,129 | $-31,107 | $-152,109 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,493 | -31,571 | -13,328 | -8,800 | -84,588 |
| PPE Investments | -1,669 | -2,368 | -324 | -315 | -4,087 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -3 |
| Sale Of Investment | 65,350 | 6,582 | 42,920 | 23,109 | 109,730 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -2,500 |
| Investing Cash Flow | $-19,812 | $-27,357 | $29,268 | $13,994 | $18,552 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,002 | 63,700 | N/A | N/A | 47,670 |
| Common Stock Issued | 1,176 | 87,219 | 87,380 | N/A | 69,237 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -2,501 |
| Other Financing Activity | -503 | -485 | -163 | -123 | -127 |
| Financing Cash Flow | $150,675 | $150,434 | $87,217 | $-123 | $114,279 |
| Exchange Rate Effect | -25 | -73 | 5 | 89 | -21 |
| Beginning Cash Position | 75,980 | 75,980 | 75,980 | 75,980 | 95,279 |
| End Cash Position | 35,094 | 84,864 | 115,341 | 58,833 | 75,980 |
| Net Cash Flow | $-40,886 | $8,884 | $39,361 | $-17,147 | $-19,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,724 | -114,120 | -77,129 | -31,107 | -152,109 |
| Capital Expenditure | -1,669 | -2,368 | -324 | -315 | -4,287 |
| Free Cash Flow | -173,393 | -116,488 | -77,453 | -31,422 | -156,396 |